Eszopiclone Tablet, Film Coated
Product Images NDC 80425-0063

3 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 80425-0063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image)

Structure (Image)
Chemical structure diagram of eszopiclone, showing its molecular configuration with labeled atoms and bonds.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Eszopiclone 2 mg film-coated tablets packaging label. The label shows the product name and strength prominently with a quantity of 60 tablets. It includes storage instructions to keep the product at 20-25°C and notes C-IV controlled substance classification. The label displays lot number 60ESZ2925 and expiration date 09/30/2025. The product is labeled by Advanced Rx of Tennessee, LLC and references manufacturer Aurobindo Pharm Ltd.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Eszopiclone 2 mg film-coated tablet packaging label from Advanced Rx of Tennessee, LLC. The label includes storage instructions to keep the product at 20°-25°C (68°-77°F). It lists a comparison to Lunesta, shows a barcode, lot number 30ESZ21124, and expiration date 11/30/2024. The label also mentions the product is a Schedule IV controlled substance and is packaged as a quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.